Free Trial
OTCMKTS:SGIOY

Shionogi & Co., Ltd. Unsponsored ADR Q1 2027 Earnings Results & Report

Shionogi & Co., Ltd. Unsponsored ADR logo
$9.95 +0.09 (+0.86%)
As of 11:10 AM Eastern

Shionogi & Co., Ltd. Unsponsored ADR beat analyst expectations on both earnings and revenue in its Q1 2027 results, released August 3, 2026. The company reported EPS of $0.36 versus the $0.18 consensus estimate, while revenue of $1.04 billion topped the $970.69 million estimate by $72.32 million.

Earnings Announcement Details

Quarter
Q1 2027
Report Date
Time
After Market Closes

Shionogi & Co., Ltd. Unsponsored ADR EPS Results

Actual EPS
$0.36
Consensus EPS
$0.18
Beat/Miss
Beat by +$0.18
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Shionogi & Co., Ltd. Unsponsored ADR Revenue Results

Actual Revenue
$1.04 billion
Expected Revenue
$970.69 million
Beat/Miss
Beat by +$72.32 million
YoY Revenue Growth
N/A

Upcoming Earnings

Shionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027, based on past reporting schedules.

Conference Call Resources

Shionogi & Co., Ltd. Unsponsored ADR Q1 2027 Earnings FAQ

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) reported earnings of $0.36 per share for Q1 2027, beating the consensus estimate of $0.18. The report was announced on Monday, August 3, 2026.

Shionogi & Co., Ltd. Unsponsored ADR reported revenue of $1.04 billion for Q1 2027, against a consensus estimate of $970.69 million.

Shionogi & Co., Ltd. Unsponsored ADR's next earnings date is estimated for Friday, January 29, 2027. MarketBeat tracks confirmed and estimated earnings dates for Shionogi & Co., Ltd. Unsponsored ADR on the company's earnings history page.

Shionogi & Co., Ltd. Unsponsored ADR Earnings Headlines

SHIONOGI & CO LTD
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Shionogi & Co., Ltd. Unsponsored ADR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Shionogi & Co., Ltd. Unsponsored ADR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Shionogi & Co., Ltd. Unsponsored ADR and other key companies, straight to your email.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co., Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, it has grown from a pharmaceutical wholesaler into a research-focused drugmaker.

The company has a particular focus on infectious diseases, including HIV, influenza and COVID-19, and also works in areas such as pain and central nervous system disorders. Its products include Xofluza, an influenza treatment, and ensitrelvir, an oral COVID-19 antiviral marketed in Japan as Xocova.

Shionogi serves patients in Japan and international markets through its own operations and collaborations with other pharmaceutical companies. Its partnerships have supported the development and commercialization of medicines in areas including HIV treatment.

View Shionogi & Co., Ltd. Unsponsored ADR Profile